Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis
Authors:
Open Access
- 29 August 2026
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 15 (1)
Abstract
Glioma stem cells (GSCs) are key drivers of glioblastoma (GBM) tumorigenesis, invasion, therapy resistance, and recurrence and exhibit remarkable phenotypic plasticity. Stanniocalcin 1 (STC1) has been implicated in tumor progression and cancer stemness; however, its role and the molecular mechanisms through which it shapes GSC plasticity and malignant traits remain poorly understood. Here, transcriptomic RNA sequencing identified STC1 as a malignancy-associated gene enriched in GBM and mesenchymal (MES)-like GSCs. Comprehensive bioinformatic analyses further validated that STC1 was highly expressed in MES-like GBM/GSCs and closely associated with poor patient survival. Functional studies revealed that STC1 promoted multiple malignant properties of GSCs, including self-renewal, migration, invasion, tumorigenicity, and cellular plasticity. Conversely, STC1 silencing attenuated these effects. Mechanistically, STC1 activated the NOTCH1/STAT3 signaling cascade, leading to transcriptional upregulation of GFPT2, a key rate-limiting enzyme of the hexosamine biosynthetic pathway. This subsequently enhanced global O-GlcNAcylation, including modification of P65, thereby facilitating GSC plasticity and malignant progression. Genetic and pharmacological interventions targeting this signaling axis effectively mitigated the oncogenic effects driven by STC1. In conclusion, our study reveals that STC1 is a key regulator of GSC phenotypic plasticity and aggressiveness through the NOTCH1/STAT3/GFPT2/O-GlcNAcylation pathway. These results provide new mechanistic insights into GBM progression and suggest that targeting STC1-associated signaling networks may represent a potential therapeutic strategy for GBM.Keywords
This publication has 71 references indexed in Scilit:
- Stanniocalcin-1 Rescued Photoreceptor Degeneration in Two Rat Models of Inherited Retinal DegenerationMolecular Therapy, 2012
- Evolution and roles of stanniocalcinMolecular and Cellular Endocrinology, 2012
- Vascular Endothelial Growth Factor (VEGF)-D Stimulates VEGF-A, Stanniocalcin-1, and Neuropilin-2 and Has Potent Angiogenic EffectsArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Stanniocalcin 1 and Ovarian TumorigenesisJNCI: Journal of the National Cancer Institute, 2010
- Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 geneMolecular and Cellular Endocrinology, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- The stanniocalcin family of proteinsJournal of Experimental Zoology Part A: Comparative Experimental Biology, 2006
- Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer CellsEndocrinology, 2005
- Hes binding to STAT3 mediates crosstalk between Notch and JAK–STAT signallingNature Cell Biology, 2004
- Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitroGlia, 2002